<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font16">CCHFV </span>
   <span class="font16">fever </span>
   <span class="font16">hemorrhagic </span>
   <span class="font15">;:– </span>
   <span class="font15">vaccine </span>
   <span class="font15">with </span>
   <span class="font14">virus </span>
   <span class="font13">The </span>
   <span class="font13">day </span>
   <span class="font13">CCHF </span>
   <span class="font13">Crimean-Congo </span>
   <span class="font13">for </span>
   <span class="font13">strain </span>
   <span class="font12">mice </span>
   <span class="font12">was </span>
   <span class="font12">from </span>
   <span class="font12">been </span>
   <span class="font12">protection </span>
   <span class="font12">Dis. </span>
   <span class="font12">against </span>
   <span class="font12">not </span>
   <span class="font11">{background </span>
   <span class="font11">has </span>
   <span class="font11">have </span>
   <span class="font11">(i.p.) </span>
   <span class="font11">are </span>
   <span class="font11">DNA </span>
   <span class="font11">IbAr </span>
   <span class="font11">Infect </span>
   <span class="font11">challenge </span>
   <span class="font11">disease </span>
   <span class="font11">were </span>
   <span class="font11">al.Crimean-Congo </span>
   <span class="font11">antibodies </span>
   <span class="font11">immune </span>
   <span class="font11">type </span>
   <span class="font11">vaccines </span>
   <span class="font11">TCID </span>
   <span class="font11">haemorrhagic </span>
   <span class="font11">lethal </span>
   <span class="font11">margin </span>
   <span class="font11">viral </span>
   <span class="font11">responses </span>
   <span class="font11">{border-style </span>
   <span class="font11">Med </span>
   <span class="font11">Trop </span>
   <span class="font11">neutralizing </span>
   <span class="font11">which </span>
   <span class="font11">(Table </span>
   <span class="font11">cell </span>
   <span class="font11">mouse </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">IFNAR−/− </span>
   <span class="font11">Virol. </span>
   <span class="font11">animal </span>
   <span class="font11">cases </span>
   <span class="font11">human </span>
   <span class="font11">infection </span>
   <span class="font11">Crimean–Congo </span>
   <span class="font11">fever. </span>
   <span class="font11">vitro </span>
   <span class="font10">after </span>
   <span class="font10">antibody </span>
   <span class="font10">could </span>
   <span class="font10">pfu </span>
   <span class="font10"> μg </span>
   <span class="font10">Crimean </span>
   <span class="font10">can </span>
   <span class="font10">encoding </span>
   <span class="font10">glycoproteins </span>
   <span class="font10">model </span>
   <span class="font10">reported </span>
   <span class="font10">vector </span>
   <span class="font10">(i.m.) </span>
   <span class="font10">Hyg. </span>
   <span class="font10">complete </span>
   <span class="font10">described </span>
   <span class="font10">protein </span>
   <span class="font10">risk </span>
   <span class="font10">GPC </span>
   <span class="font10">Res. </span>
   <span class="font10">animals </span>
   <span class="font10">proteins </span>
   <span class="font10">studies </span>
   <span class="font10">Emerg </span>
   <span class="font10">clinical </span>
   <span class="font10">compared </span>
   <span class="font10">knockout </span>
   <span class="font10">models </span>
   <span class="font10">recombinant </span>
   <span class="font10">virus. </span>
   <span class="font10">(s.c.) </span>
   <span class="font10">dose </span>
   <span class="font10">efficacy </span>
   <span class="font10">expression </span>
   <span class="font10">infected </span>
   <span class="font10">interferon </span>
   <span class="font10">observed </span>
   <span class="font10">using </span>
   <span class="font10">virus-like </span>
   <span class="font10">;:e </span>
   <span class="font10">Ank- </span>
   <span class="font10">Turkey-Kelkit </span>
   <span class="font10">but </span>
   <span class="font10">cells </span>
   <span class="font10">development </span>
   <span class="font10">evidence </span>
   <span class="font10">following </span>
   <span class="font10">gene </span>
   <span class="font10">high </span>
   <span class="font10">livestock </span>
   <span class="font10">particle </span>
   <span class="font10">protective </span>
   <span class="font10">this </span>
   <span class="font10">tick </span>
   <span class="font10">BoHV- </span>
   <span class="font10">PLoS </span>
   <span class="font10">boost </span>
   <span class="font10">expressing </span>
   <span class="font10">genetic </span>
   <span class="font10">immunity </span>
   <span class="font10">include </span>
   <span class="font10">px; </span>
   <span class="font10">response </span>
   <span class="font10">single </span>
   <span class="font10">such </span>
   <span class="font10">that </span>
   <span class="font10">thus </span>
   <span class="font10">vaccine. </span>
   <span class="font10">viruses </span>
   <span class="font10">who </span>
   <span class="font10">{font-family </span>
   <span class="font10">Africa. </span>
   <span class="font10">Antivir </span>
   <span class="font10">RNA </span>
   <span class="font10">Vaccine </span>
   <span class="font10">al.A </span>
   <span class="font10">based </span>
   <span class="font10">case </span>
   <span class="font10">either </span>
   <span class="font10">elicited </span>
   <span class="font10">enhance </span>
   <span class="font10">envelope </span>
   <span class="font10">first </span>
   <span class="font10">font-size </span>
   <span class="font10">group </span>
   <span class="font10">groups </span>
   <span class="font10">higher </span>
   <span class="font10">infection. </span>
   <span class="font10">infections </span>
   <span class="font10">mice. </span>
   <span class="font10">models. </span>
   <span class="font10">outbreak </span>
   <span class="font10">particles </span>
   <span class="font10">prime </span>
   <span class="font10">replicon </span>
   <span class="font10">study </span>
   <span class="font10">there </span>
   <span class="font10">tick-borne </span>
   <span class="font10">ticks </span>
   <span class="font10">transfer </span>
   <span class="font10">transmission </span>
   <span class="font10">Bulgarian </span>
   <span class="font10">Congo </span>
   <span class="font10">absence </span>
   <span class="font10">although </span>
   <span class="font10">animals, </span>
   <span class="font10">antigen </span>
   <span class="font10">between </span>
   <span class="font10">blood </span>
   <span class="font10">bovine </span>
   <span class="font10">candidate </span>
   <span class="font10">construct </span>
   <span class="font10">countries </span>
   <span class="font10">described. </span>
   <span class="font10">double; </span>
   <span class="font10">during </span>
   <span class="font10">endemic </span>
   <span class="font10">global </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">herpesvirus </span>
   <span class="font10">humans. </span>
   <span class="font10">levels </span>
   <span class="font10">produced </span>
   <span class="font10">protected </span>
   <span class="font10">provided </span>
   <span class="font10">serum </span>
   <span class="font10">some </span>
   <span class="font10">strain, </span>
   <span class="font10">though </span>
   <span class="font10">tissue </span>
   <span class="font10">titers </span>
   <span class="font10">vaccination </span>
   <span class="font10">vivo. </span>
   <span class="font10">well </span>
   <span class="font10">(Ank- </span>
   <span class="font10">African </span>
   <span class="font10">Asia, </span>
   <span class="font10">BMC </span>
   <span class="font10">Besides </span>
   <span class="font10">Clin </span>
   <span class="font10">Even </span>
   <span class="font10">Health </span>
   <span class="font10">However, </span>
   <span class="font10">Immunol. </span>
   <span class="font10">In: </span>
   <span class="font10">Int </span>
   <span class="font10">Med. </span>
   <span class="font10">NP-based </span>
   <span class="font10">Negl </span>
   <span class="font10">Oman- </span>
   <span class="font10">Open </span>
   <span class="font10">Soc </span>
   <span class="font10">VRP </span>
   <span class="font10">ability </span>
   <span class="font10">adenovirus </span>
   <span class="font10">administered </span>
   <span class="font10">analysis </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">did </span>
   <span class="font10">different </span>
   <span class="font10">displayed </span>
   <span class="font10">fever, </span>
   <span class="font10">inactivated </span>
   <span class="font10">investigated </span>
   <span class="font10">mRNA </span>
   <span class="font10">modified </span>
   <span class="font10">newborn </span>
   <span class="font10">other </span>
   <span class="font10">plants </span>
   <span class="font10">population </span>
   <span class="font10">presence </span>
   <span class="font10">rate </span>
   <span class="font10">responses, </span>
   <span class="font10">route </span>
   <span class="font10">serological </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">strain) </span>
   <span class="font10">strains </span>
   <span class="font10">survival </span>
   <span class="font10">target </span>
   <span class="font10">these </span>
   <span class="font10">two </span>
   <span class="font10">use </span>
   <span class="font10">vectors </span>
   <span class="font10">virus, </span>
   <span class="font10">whereas </span>
   <span class="font10">while </span>
   <span class="font10">years </span>
   <span class="font10">yet </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(CCHF) </span>
   <span class="font10">.KimJJ, </span>
   <span class="font10">AdV- </span>
   <span class="font10">Africa, </span>
   <span class="font10">Arab </span>
   <span class="font10">Arch </span>
   <span class="font10">CCHFV, </span>
   <span class="font10">CHF </span>
   <span class="font10">Central </span>
   <span class="font10">Cynomolgus </span>
   <span class="font10">Despite </span>
   <span class="font10">Development </span>
   <span class="font10">East </span>
   <span class="font10">Hoti </span>
   <span class="font10">Hyalomma </span>
   <span class="font10">IL-, </span>
   <span class="font10">IgG </span>
   <span class="font10">MVA-NP </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">Middle </span>
   <span class="font10">NP, </span>
   <span class="font10">Rift </span>
   <span class="font10">South </span>
   <span class="font10">This </span>
   <span class="font10">Turkey </span>
   <span class="font10">United </span>
   <span class="font10">Vaccines </span>
   <span class="font10">adoptive </span>
   <span class="font10">antigens </span>
   <span class="font10">available </span>
   <span class="font10">because </span>
   <span class="font10">bold </span>
   <span class="font10">cellular </span>
   <span class="font10">challenged </span>
   <span class="font10">circulation </span>
   <span class="font10">constructs </span>
   <span class="font10">contact </span>
   <span class="font10">correlates </span>
   <span class="font10">courier; </span>
   <span class="font10">delivered </span>
   <span class="font10">demonstrated </span>
   <span class="font10">developed </span>
   <span class="font10">development. </span>
   <span class="font10">differences </span>
   <span class="font10">disease. </span>
   <span class="font10">em; </span>
   <span class="font10">epitopes </span>
   <span class="font10">especially </span>
   <span class="font10">explored </span>
   <span class="font10">features </span>
   <span class="font10">further </span>
   <span class="font10">genome </span>
   <span class="font10">humanized </span>
   <span class="font10">humans </span>
   <span class="font10">immunized </span>
   <span class="font10">induction </span>
   <span class="font10">infection, </span>
   <span class="font10">intraperitoneally </span>
   <span class="font10">investigation </span>
   <span class="font10">laboratory </span>
   <span class="font10">likely </span>
   <span class="font10">macaque </span>
   <span class="font10">model, </span>
   <span class="font10">neutralization </span>
   <span class="font10">nucleoprotein </span>
   <span class="font10">only </span>
   <span class="font10">outcomes </span>
   <span class="font10">passive </span>
   <span class="font10">patients </span>
   <span class="font10">performed. </span>
   <span class="font10">plasmid </span>
   <span class="font10">production </span>
   <span class="font10">pt;} </span>
   <span class="font10">role </span>
   <span class="font10">since </span>
   <span class="font10">stomatitis </span>
   <span class="font10">strain)NP </span>
   <span class="font10">strain. </span>
   <span class="font10">strategy </span>
   <span class="font10">subcutaneous </span>
   <span class="font10">suppressed </span>
   <span class="font10">system </span>
   <span class="font10">three </span>
   <span class="font10">through </span>
   <span class="font10">times </span>
   <span class="font10">tissues </span>
   <span class="font10">used </span>
   <span class="font10">vaccinated </span>
   <span class="font10">would </span>
   <span class="font10"> × (-week </span>
  </p>
 </body>
</html>
